Literature DB >> 2402301

[3H] GR67330, a very high affinity ligand for 5-HT3 receptors.

G J Kilpatrick1, A Butler, R M Hagan, B J Jones, M B Tyers.   

Abstract

GR67330 potently inhibited 5-hydroxytryptamine (5-HT)-induced depolarizations of the rat isolated vagus nerve. At the higher concentrations used (0.3 nmol/l-1 nmol/l) this was accompanied by a marked reduction in the maximum response to 5-HT. The calculated pKB value was 10.2. The binding of the tritiated derivative of GR67330 to homogenates of rat entorhinal cortex was examined. Kinetic analysis revealed that specific [3H] GR67330 (0.1 nmol/l) binding was rapid and reversible. Association and dissociation rate constants were 1.48 +/- 0.36 x 10(8) mol/l-1 s-1 and 7.85 +/- 0.41 x 10(-3) s-1 respectively. Equilibrium saturation analysis revealed specific binding was to a single site (Bmax 22.6 +/- 0.21 fmol/mg protein) of high affinity (Kd 0.038 +/- 0.003 nmol/l). At low ligand concentrations, specific binding was up to 90% of total binding. If unlabelled GR67330 was used to define non-specific binding two sites were evident (Kd1 0.066 +/- 0.007 nmol/l, Kd2 20.1 +/- 9.7 nmol/l; Bmax1 31.5 +/- 3.2 fmol/mg protein, Bmax2 1110 +/- 420 fmol/mg protein). [3H] GR67330 binding was inhibited potently by 5-HT3 antagonists and agonists. Ligands for other 5-HT receptors and other neurotransmitter receptors were either only weakly active or inactive at inhibiting binding. Hill numbers for antagonist inhibition of binding were close to unity, except for quipazine which was significantly greater than one. In common with other 5-HT3 binding studies, all 5-H-agonist tested had Hill numbers greater than one (1.51-1.71). GR38032 and GR65630 inhibited a greater proportion of binding than other 5-HT3 antagonists, this additional binding was interpreted as inhibition from a second saturable site unrelated to the 5-HT3 receptor.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2402301     DOI: 10.1007/bf00178967

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.

Authors:  G J Kilpatrick; B J Jones; M B Tyers
Journal:  Nature       Date:  1987 Dec 24-31       Impact factor: 49.962

2.  Identification of serotonin 5-HT3 recognition sites by radioligand binding in NG108-15 neuroblastoma-glioma cells.

Authors:  D Hoyer; H C Neijt
Journal:  Eur J Pharmacol       Date:  1987-11-10       Impact factor: 4.432

Review 3.  Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.

Authors:  G A Weiland; P B Molinoff
Journal:  Life Sci       Date:  1981-07-27       Impact factor: 5.037

4.  Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride.

Authors:  N M Barnes; B Costall; J W Ironside; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1988-09       Impact factor: 3.765

5.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

6.  Characterization of [3H]quipazine binding to 5-hydroxytryptamine3 receptors in rat brain membranes.

Authors:  C M Milburn; S J Peroutka
Journal:  J Neurochem       Date:  1989-06       Impact factor: 5.372

7.  Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve.

Authors:  S J Ireland; M B Tyers
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

8.  Some effects of 5-hydroxytryptamine, dopamine and noradrenaline on neurones in the submucous plexus of guinea-pig small intestine.

Authors:  G D Hirst; E M Silinsky
Journal:  J Physiol       Date:  1975-10       Impact factor: 5.182

9.  MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

Authors:  J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

10.  The depolarizing action of 5-hydroxytryptamine on rabbit vagal afferent and sympathetic neurones in vitro and its selective blockade by ICS 205-930.

Authors:  A Round; D I Wallis
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

View more
  8 in total

1.  Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.

Authors:  G J Molderings; D Frölich; J Likungu; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

2.  Role of the abdominal vagus and hindbrain in inhalational anesthesia-induced vomiting.

Authors:  Ragini G Gupta; Claire Schafer; Yolande Ramaroson; Michael G Sciullo; Charles C Horn
Journal:  Auton Neurosci       Date:  2016-07-02       Impact factor: 3.145

3.  The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues.

Authors:  A Butler; C J Elswood; J Burridge; S J Ireland; K T Bunce; G J Kilpatrick; M B Tyers
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

4.  Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells.

Authors:  A G Hope; J A Peters; A M Brown; J J Lambert; T P Blackburn
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

5.  Single amino acid substitution affects desensitization of the 5-hydroxytryptamine type 3 receptor expressed in Xenopus oocytes.

Authors:  J L Yakel; A Lagrutta; J P Adelman; R A North
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

6.  Agonist interactions with 5-HT3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands.

Authors:  J M Barnes; N M Barnes; B Costall; S M Jagger; R J Naylor; D W Robertson; S Y Roe
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

Review 7.  Role of the serotonergic system in alcohol dependence: from animal models to clinics.

Authors:  Youssef Sari; Verity R Johnson; Jason M Weedman
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

8.  Dopamine releasing effect of phenylbiguanide in rat striatal slices.

Authors:  M Benuck; M E Reith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.